Использование сетевого подхода к анализу бизнес-модели: пример российского фармацевтического рынка

Denis E. Klimanov; Olga A. Tretyak

doi:10.21638/11701/spbu18.2016.204

Authors

Denis E. Klimanov National Research University Higher School of Economics, Moscow, Russia https://orcid.org/0000-0003-3572-8694
Olga A. Tretyak National Research University Higher School of Economics, Moscow, Russia https://orcid.org/0000-0001-7072-4117

DOI:

https://doi.org/10.21638/11701/spbu18.2016.204

Abstract

This article elaborates upon the paper by O. Tretyak and D. Klimanov published in the Russian Management Journal vol. 14, issue 1. It demonstrates a practical application of the approach to business model (BM) analysis and change management, developed by the authors and based on organizational networks theory. The study is devoted to the example of Russian pharmaceutical market and the international manufacturing company that specializes in ophthalmology, medical aesthetics and neurosciences. The results obtained are based on a number of expert interviews with the representatives of company management. In line with three suggested levels of BM analysis, the authors conducted a sequence of procedures that allowed not only to highlight the specifics of the approach and clarify it, but also to offer concrete directions for BM change in order to increase the value that is jointly created by BM actors for the final consumer.

Keywords:

business models, value chains, pharmaceutical market, Russia

Downloads

Download data is not yet available.

References

ЛИТЕРАТУРА НА РУССКОМ ЯЗЫКЕ

Федеральный закон от 21.11.2011 № 323-ФЗ (ред. от 06.04.2015) «Об основах охраны здоровья граждан в Российской Федерации».

Гиротра К., Нетесин С. 2014. Оптимальная бизнес-модель: Четыре инструмента управления рисками. М.: Альпина Паблишер.

Ильин Г. А. 2011. Штрафная рота. За последние 15 лет фармкомпании потратили на штрафы 12 млрд долл. Фармацевтический вестник (30). http://www.pharmvestnik.ru/publs/staryj-arxiv-gazety/27047.html#.Vq38KLKLTIU

Климанов Д. Е., Третьяк О. А. 2014. Бизнес-модели: основные направления исследований и поиски содержательного фундамента концепции. Российский журнал менеджмента 12 (3): 107–130.

Третьяк О. А., Климанов Д. Е. 2016. Новый подход к анализу бизнес-моделей. Российский журнал менеджмента 14 (1): 115–130.

Третьяк О. А., Слоев И. А. 2012. Оценка маркетинговой деятельности по состоянию клиентского потока. Российский журнал менеджмента 10 (1): 29–50.

Synovate Comcon. 2015. Дайджест исследования конечных потребителей (Вып. XVII): Факторы выбора безрецептурных препаратов потребителями и возможные причины отказа от покупки в аптеке.

REFERENCES IN LATIN ALPHABET

Borgatti S. P., Everett M. G. 2006. A graphtheoretic perspective on centrality. Social Networks 28 (4): 466–484.

Bournias T. E., Lai J. 2009. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs. Ophthalmology 116 (9): 1719–1724.

Christopher M. 2011. Logistics & Supply Chain Management. Financial Times / Prentice Hall: Harlow, England; N. Y.

Gassmann O., Frankenberger K., Csik M. 2013. The St. Gallen Business Model Navigator. Working Paper, University of St. Gallen, St. Gallen, Switzerland.

Mentzer J. T. et al. 2001. Defining supply chain management. Journal of Business Logistics 22 (2): 1–25.

Osterwalder A ., Pigneur Y. 2004. An ontology for e-business models. In: Currie W. (ed.). Value Creation From E-business Models. Butterworth-Heinemann: Oxford; 65–97.

Osterwalder A ., Pigneur Y. 2010. Business Model Generation: A Handbook for Visionaries, Game Changers, and Challengers. John Wiley & Sons.

Seidmann A ., Sundararajan A . 1997. The effects of task and information asymmetry on business process redesign. International Journal of Production Economics 50 (2): 117–128.

Translation of references in Russian into English

The Federal Law of Russian Federation N 323-FZ “On the basis of public health protection in the Russian Federation” (from 21.11.2011, edited version from 06.04.2015).

Girotra K., Netessine S. 2014. The risk-driven business model: Four questions that will define your company. Russian translation. M.: Al’pina Pablisher.

Ilyin G. A . 2011. The penalty company. Over the past 15 years, drug companies have spent $12 billion on fines. Farmatsevticheskii vestnik (30). http://www.pharmvestnik.ru/publs/staryj-arxiv-gazety/27047.html#.Vq38KLKLTIU

Klimanov D. E., Tretyak O. A . 2014. Business models: Major research directions and search of conceptual foundations. Rossiiskii zhurnal menedzhmenta 12 (3): 107–130.

Tretyak O. A ., Klimanov D. E. 2016. New approach to business model analysis. Rossiiskii zhurnal menedzhmenta 14 (1): 115–130.

Tretyak O. A ., Sloev I. A . 2012. Client’s flow based evaluation of marketing activities. Rossiiskii zhurnal menedzhmenta 10 (1): 29–50.

Synovate Comcon. 2015. The digest of the research on end-users (issue XVII): OTC selection factors by consumers and the possible reasons for not buying in a drugstore.